Association and expression analyses with single-nucleotide polymorphisms in TOMM40 in Alzheimer disease.
暂无分享,去创建一个
David M Holtzman | A. Fagan | J. Morris | D. Holtzman | A. Goate | P. Nowotny | K. Mayo | Carlos Cruchaga | J. Kauwe | P. Ridge | A. Hinrichs | S. Bertelsen | Anne M Fagan | John C Morris | Carlos Cruchaga | John S K Kauwe | Kevin Mayo | Sarah Bertelsen | Petra Nowotny | Anthony Hinrichs | Perry G Ridge | Alison M Goate | J. Morris | J. Morris | J. Morris
[1] Thomas W. Mühleisen,et al. Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease , 2013, Nature Genetics.
[2] A. Fagan,et al. Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults. , 2007, Archives of neurology.
[3] A. J. Slater,et al. Candidate single-nucleotide polymorphisms from a genomewide association study of Alzheimer disease. , 2008, Archives of neurology.
[4] A. Fagan,et al. Extreme cerebrospinal fluid amyloid β levels identify family with late‐onset Alzheimer's disease presenilin 1 mutation , 2007, Annals of neurology.
[5] M. Gill,et al. Evidence for novel susceptibility genes for late-onset Alzheimer's disease from a genome-wide association study of putative functional variants. , 2007, Human molecular genetics.
[6] Eden R Martin,et al. Genome-wide association study implicates a chromosome 12 risk locus for late-onset Alzheimer disease. , 2009, American journal of human genetics.
[7] A. Fagan,et al. Validating predicted biological effects of Alzheimer's disease associated SNPs using CSF biomarker levels. , 2010, Journal of Alzheimer's disease : JAD.
[8] Rebecca F. Halperin,et al. A high-density whole-genome association study reveals that APOE is the major susceptibility gene for sporadic late-onset Alzheimer's disease. , 2007, The Journal of clinical psychiatry.
[9] D. Stephan,et al. A survey of genetic human cortical gene expression , 2007, Nature Genetics.
[10] Ellen M Wijsman,et al. Comprehensive analysis of APOE and selected proximate markers for late-onset Alzheimer's disease: patterns of linkage disequilibrium and disease/marker association. , 2007, Genomics.
[11] A D Roses,et al. A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease , 2009, The Pharmacogenomics Journal.
[12] Andrey Alexeyenko,et al. Genome-wide pathway analysis implicates intracellular transmembrane protein transport in Alzheimer disease , 2010, Journal of Human Genetics.
[13] M Krawczak,et al. Examination of the current top candidate genes for AD in a genome-wide association study , 2010, Molecular Psychiatry.
[14] D. Stephan,et al. Genetic control of human brain transcript expression in Alzheimer disease. , 2009, American journal of human genetics.
[15] Gina N. LaRossa,et al. Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans , 2006, Annals of neurology.
[16] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS—ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease , 2011, Neurology.
[17] A. Fagan,et al. SNPs Associated with Cerebrospinal Fluid Phospho-Tau Levels Influence Rate of Decline in Alzheimer's Disease , 2010, PLoS genetics.
[18] Peter Imle,et al. Fluorescence-based fragment size analysis. , 2005, Methods in molecular biology.
[19] A. Fagan,et al. Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition , 2008, Proceedings of the National Academy of Sciences.
[20] M. Cuccaro,et al. Multiple rare SAPAP3 missense variants in trichotillomania and OCD , 2009, Molecular Psychiatry.
[21] V. Pankratz,et al. Genetic variation in PCDH11X is associated with susceptibility to late-onset Alzheimer's disease , 2009, Nature Genetics.
[22] P. Bosco,et al. Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease , 2009, Nature Genetics.
[23] K. Lunetta,et al. Meta-analysis confirms CR1, CLU, and PICALM as alzheimer disease risk loci and reveals interactions with APOE genotypes. , 2010, Archives of neurology.
[24] Christoph Lange,et al. Genome-wide association analysis reveals putative Alzheimer's disease susceptibility loci in addition to APOE. , 2008, American journal of human genetics.
[25] Peter Donnelly,et al. A comparison of bayesian methods for haplotype reconstruction from population genotype data. , 2003, American journal of human genetics.
[26] April N. Allen,et al. Genome-Wide Association Study for Alzheimer's Disease Risk in a Large Cohort Of Clinically Characterized And Neuropathologically Verified Subjects , 2010, Alzheimer's & Dementia.
[27] J. Price,et al. Clinicopathologic studies in cognitively healthy aging and Alzheimer's disease: relation of histologic markers to dementia severity, age, sex, and apolipoprotein E genotype. , 1998, Archives of neurology.
[28] R. Petersen,et al. Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects , 2009, Annals of neurology.
[29] Winnie S. Liang,et al. GAB2 Alleles Modify Alzheimer's Risk in APOE ɛ4 Carriers , 2007, Neuron.